National Inferior Vena Cava (IVC) Filter Registry

This study has been terminated.
Information provided by (Responsible Party):
American Venous Forum Identifier:
First received: June 3, 2011
Last updated: June 20, 2013
Last verified: June 2013

Inferior vena cava (IVC) filter is an important therapeutic device used in the management of venous thrombo-embolism (VTE) in patients that are contra-indicated for anti-coagulation therapy. While there has been significant increase in the use of filters , unfortunately there are no standardized collection of data to track, compare outcomes, report safety and efficacy.

Venous Thrombo-embolism

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: IVC Filter Study to Monitor and Measure Patients Outcomes Through Standardized Collection and Analysis of Clinical Information

Resource links provided by NLM:

Further study details as provided by American Venous Forum:

Primary Outcome Measures:
  • Integrity of IVC Filter 12 months post placement [ Time Frame: 48 Months ] [ Designated as safety issue: Yes ]

Enrollment: 20000
Study Start Date: May 2011
Estimated Study Completion Date: May 2014
Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Detailed Description:

The registry is a multi-institutional bioinformatics database for the collection of data relevant to Inferior vena cava filters. Participating study centers may enroll patients and enter data in the web-based registry that include demographics, clinical features, management details and follow-up up to 48 months.

The purpose of this study is to improve our understanding of the retrieval rate, long term safety and efficacy on IVC filters placed in North America.


Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

No specific criteria. Data from anyone who underwent IVC Filter Placement/Retrieval will be eligible


Inclusion Criteria:

  • Data obtained in line with good clinical practice,applicable laws and regulation
  Contacts and Locations
Please refer to this study by its identifier: NCT01367184

  Show 27 Study Locations
Sponsors and Collaborators
American Venous Forum
Study Chair: Brajesh K Lal University of Maryland Medical Center,Baltimore
Principal Investigator: John E. Rectenwald University of Michigan
Study Director: Uchenna N Onyeachom American Venous Forum
  More Information

Additional Information:
No publications provided

Responsible Party: American Venous Forum Identifier: NCT01367184     History of Changes
Other Study ID Numbers: AVR-IVC-01
Study First Received: June 3, 2011
Last Updated: June 20, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by American Venous Forum:
Inferior vena cava
Venous thrombo-embolism
Outcome data
IVC Filters

Additional relevant MeSH terms:
Venous Thromboembolism
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Thrombosis processed this record on April 20, 2014